VOICED : AstraZeneca anuncia pausa en ensayos clínicos de su vacuna contra covid-19

VOICED : AstraZeneca anuncia pausa en ensayos clínicos de su vacuna contra covid-19

Assessment

Interactive Video

Biology, Science, Health

9th - 12th Grade

Hard

Created by

Wayground Content

FREE Resource

AstraZeneca has paused its COVID-19 vaccine trials due to an unexplained illness in a participant. The company is conducting a routine safety review to ensure trial integrity. The vaccine, developed in partnership with Oxford University, is in Phase III trials and has been tested in multiple countries. It uses a weakened adenovirus to trigger an immune response against the coronavirus.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why did AstraZeneca pause its COVID-19 vaccine trials?

Because of an unexplained illness in a participant

Due to a lack of volunteers

The vaccine was found to be ineffective

The trials were completed

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which university is AstraZeneca collaborating with for the COVID-19 vaccine?

University of Oxford

University of Cambridge

Stanford University

Harvard University

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

In which countries has AstraZeneca's vaccine been tested?

United States, Canada, Mexico

United Kingdom, Brazil, South Africa, United States

India, China, Japan

Australia, New Zealand, Singapore

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What type of virus is used in AstraZeneca's vaccine to trigger an immune response?

A flu virus

A bacterial strain

A weakened adenovirus

A live coronavirus

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What does the protein produced by the vaccine do?

It causes the coronavirus to mutate

It helps the immune system recognize and fight the coronavirus

It destroys the coronavirus directly

It prevents the coronavirus from entering the body